Nanomedicine News

RSS

Micro-Scaled Photovoltaic Devices May Find Application in Chemotherapy

Micro-scaled photovoltaic devices may one day be used to deliver chemotherapeutic drugs directly to tumors, rendering chemotherapy less toxic to surrounding tissue.

21 Oct 2010

PSI Signs Licensing and Technology Development Agreement with SoluBest

Particle Sciences Inc. (PSI), a leading pharmaceutical CRO and SoluBest have entered into a licensing and technology development agreement. Under the agreement, Particle Sciences will be the exclusive contract researc...

20 Oct 2010

Researchers to Test Nanoparticle-Based Theranostics for Treating Pancreatic Cancer

Researchers from Rice University's Laboratory for Nanophotonics (LANP), the radiology department at Baylor College of Medicine (BCM) and the University of Texas MD Anderson Cancer Center are preparing to test a combi...

19 Oct 2010

Nanotope Teams Up with Smith + Nephew to Develop Cartilage Regeneration Product

Arrowhead Research Corporation today announced that its portfolio company, Nanotope, Inc., has entered into an agreement with Smith & Nephew, Inc., a member of the Smith & Nephew plc group to develop a cartilage regeneration product for human healthcare markets using a subset of its proprietary regenerative medicine technology.

From Arrowhead Pharmaceutical 19 Oct 2010

Manhattan Scientifics to Sign Letter of Intent with NanoMet

Manhattan Scientifics, Inc. (OTC: MHTX) announced that at today’s historic press conference introducing the use of the first FDA-approved dental implant made with nanotitanium, the company will sign a letter of int...

From Manhattan Scientifics Inc. 18 Oct 2010

Shrink Nanotechnologies Reveals Image of First Biomedical Research Tool

Shrink Nanotechnologies, Inc. ("Shrink") (OTC Bulletin Board: INKN), an innovative nanotechnology company developing products and licensing opportunities in the alternative energy industry, medical diagnostics and sensors and biotechnology research and development tools businesses, revealed an image of its first product offering – the StemDisc450™, a high-yield, low cost, patent-pending cell culturing biomedical research tool. Shrink expects to begin offering this product for sale in the latter part of 2010.

18 Oct 2010

New Xagenic Technology Analyzes Cell’s Genetic Material

MaRS Innovation today announced a $500,000 investment in the Toronto company, Xagenic Inc.

18 Oct 2010

NIH Funding Supports Development of Lipid Nanoparticle Technology-Based Candidate for Ebola Treatment

Tekmira Pharmaceuticals Corporation, a leader in RNA interference (RNAi) therapeutics, announced today that, together with collaborators at The University of Texas Medical Branch, it has been awarded a new United States National Institutes of Health (NIH) grant to support research to develop RNAi therapeutics to treat Ebola and Marburg hemorrhagic fever viral infections using Tekmira's lipid nanoparticle (LNP) delivery technology.

15 Oct 2010

Stony Brook University Professor Receives NIH Grant for Groundbreaking Work in Nanomedicine

Balaji Sitharaman, Ph.D., Assistant Professor of Biomedical Engineering at Stony Brook University, is a 2010 recipient of the National Institutes of Health (NIH) Director’s New Innovator Award.

15 Oct 2010

First Nanotitanium Dental Implant to be Placed in the Mouth of Co-Inventor

A group of ground-breaking American and Russian scientists, led by Dr. Terry Lowe, chief scientist at Manhattan Scientifics (OTCBB: MHTX) are taking Cold War weapons technology and repurposing it for peaceful use in medi...

14 Oct 2010